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Abstract
Rapidly growing and highly vascularized tumors, such as glioblastoma multiforme, contain heterogeneous areas within the
tumor mass, some of which are inefficiently supplied with nutrients and oxygen. While the cell death rate is elevated in such
zones, tumor cells are still suspected to grow and survive independently of extracellular growth factors. In line with this,
glioblastoma stem-like cells (GSCs) are found closely associated with brain vasculature in situ, and as such are most likely in a
protected microenvironment. However, the behavior of GSCs under deprived conditions has not been explored in detail.
Using a panel of 14 patient-derived GSCs, we report that ex vivo mitogen deprivation impaired self-renewal capability,
abolished constitutive activation of the mTor pathway, and impinged on GSC survival via the engagement of autophagic
and apoptotic cascades. Moreover, pharmacological inhibition of the mTor pathway recapitulated the mitogen deprivation
scenario. In contrast, blocking either apoptosis or autophagy, or culturing GSCs with endothelial-secreted factors partly
restored mTor pathway activation and rescued GSC survival. Overall, our data suggest that GSCs are addicted to mTor, as
their survival and self-renewal are profoundly dependent on this signaling axis. Thus, as mTor governs the fate of GSCs
under both deprivation conditions and in the presence of endothelial factors, it could be a key target for therapeutic
purposes.
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Introduction
Adult glioblastoma multiforme (GBM) is the most common
primary brain tumor. Patients with malignant glioma have poor
prognosis due to local recurrence. Despite surgery, radiotherapy
and temozolomide chemotherapy, less than 10% of patients reach
a 5-year survival [1]. GBMs comprise a subpopulation of cells,
which retain the ability to expand ex vivo as neurospheres in
mitogen-defined medium and recapitulate tumor formation in
mice [2,3]. These so-called glioblastoma stem-like cells (GSCs)
share many characteristics with normal stem cells, including self-
renewal and multipotency [3]. One major mechanism that
eliminates undesired and potentially toxic cells is apoptosis [4].
However, whether apoptosis contributes to limit stem cell
expansion has not been completely elucidated. For instance, we
have shown that adult human mesenchymal stem cells do not
undergo apoptosis when left undifferentiated [5]. Moreover, the
impact of apoptosis on stem cells and cancer stem-like cells during
tissue regeneration and tumor progression is not known. The
manipulation of autophagy has also been suggested as a valuable
strategy to prevent cancer development, limit tumor progression
and increase the efficacy of cancer treatments [6]. Therefore,
while GBMs are generally resistant to therapies that induce
apoptosis, they might be more sensitive to those targeting
autophagy [7]. However, the molecular mechanisms governing
the interplay between autophagy and apoptotic cell death in GSCs
remain to be elucidated.
Although neo-angiogenesis is believed to overcome growing
tumor needs, inner zones within the tumor mass are not always
efficiently irrigated and an increase in the tumor cell death rate
can occur as a consequence of starved conditions [8]. Likewise,
penury can be provoked upon administration of chemotherapeutic
and anti-angiogenic agents. Indeed, GSCs can be suppressed
along with tumor endothelial cells in response to anti-vascular
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endothelial growth factor antibody challenge [9]. Here, we show
that mitogen deprivation induces both autophagy and apoptosis in
patient-derived GSCs. This effect is largely dependent on
mammalian target of rapamycin (mTOR) activation and can be
alleviated by the endothelial cell secretome. Moreover, blockade of
either autophagy or apoptosis can restore the activation of mTor.
In agreement with its role in sensing microenvironmental
conditions, mTor could thus chiefly orchestrate the fate of the
GSC population.
Materials and Methods
Cell culture
Patient-derived GSCs#1 to 4 were described previously in [10–
13], GSCs #5 to 14 were obtained from Hospital Laennec,
Nantes, France. Briefly, tumors were dissociated using the
gentleMACs Dissociator (Miltenyi), according to the manufactur-
er’s instructions. GSCs #1 to 14 were maintained in DMEM/F12
plus N2, G5 and B27 (Life Technologies). These three supple-
ments were omitted when cells were cultured under mitogen
deprivation. Differentiated GSCs were obtained by dissociation
and cultured in DMEM plus 10% FBS and 1% penicillin/
streptomycin (Life Technologies). Concomitant increase in the
differentiation marker GFAP and decrease in the stemness
markers Nestin and Sox2 were observed after 3 days of adhesion.
Immortalized human brain microvascular endothelial cells
(hCMEC/D3) were expanded as described previously [11–14].
Conditioned media from hCMEC/D3 (EC-CM) were obtained
from 72h-old monolayers cultured in serum-free EBM2 (Lonza), as
previously described [11].
Ethics statement
Patients all signed a written informed consent before sample
collection, which occurred for diagnostic purposes. This study was
reviewed and approved by an institutional review board (Sainte
Anne Hospital, Paris, France, and Laennec Hospital, Nantes,
France). This study abides the rules of the Helsinki Protocol.
Reagents and antibodies
Rapamycin and PI103 were purchased from MERCK,
LY294002 from Tocris, PP242 from Sigma, quinolyl-valyl-O-
methylaspartyl-[–2,6-difluorophenoxy]-methyl ketone (QVD) was
from R&D systems. The following antibodies were used: phospho
(p)S-Akt, pT-Akt, p-S6, p-4EBP1, pAMPK, pACC, LC3B, Atg12,
Bim, Caspase 3, and Bcl-2 (Cell Signaling Technology), Cyto-
chrome-c and Tubulin (Santa Cruz), Sox2 (Millipore), and GFAP
(Sigma). Stealth non-silencing control and selected siRNA for
human Beclin were from Life Technologies. Transfections were
performed using RNAiMAX lipofectamine (Life Technologies).
Alexa488- and Alexa546-conjugated antibodies were purchased
from Life Technologies.
Secondary neurosphere formation
GSCs were dissociated by up-and-down pipetting and cultured
in a 48-well plate format. Cells were dissociated again at days 1
and 2 after mitogen deprivation and then maintained until day 3.
Neurosphere (NS) counts were blindly performed on five random
fields of view (fov) and the mean of NS/fov was calculated from 3
independent experiments. Statistical analyses were performed
using two-way Student’s test.
RT-PCR
RNA was extracted using the RNeasy Mini Kit as per the
manufacturer’s directions (Qiagen). Equal amounts of RNA were
reverse transcribed using the Maxima Reverse Transcriptase
(Thermo Scientific) and the resulting cDNA was used to amplify
Nestin and Sox2 transcripts by PCR using gene-specific primers
for human Sox2 (Fwd: 59-CAAAAATGGCCATGCAGGTT-39;
Rev: 59-AGTTGGGATCGAACAAAAGCTATT-39) and human
Nestin (Fwd: 59-TTCTCTTGTCCCGCAGACTT-39; Rev: 59
AACAGCGACGGAGGTCTCTA-39) in the presence of RedTaq
Mix (Sigma), as described previously [15]. Human GAPDH (Fwd:
59-ACTTCACCTTCCCTCCAACC-39; Rev: 59-GGAGGAGT-
GGGTGTCGCTGT-39) was also amplified as a control for input.
PCR products were separated by electrophoresis on SYBR safe-
containing agarose gels (Life Technologies).
Western blot
Proteins were collected in TNT buffer (10 mM Tris-HCl
pH 7.5, 150 mM NaCl, 1% Triton X100, 2 mM EDTA) plus
protease inhibitors (Sigma), 200 mM NaF and 0.1 mM Na3VO4.
Equal amounts of proteins (microBCA kit, Pierce) were separated
with 4–12% Nupage gels (Life Technologies) and transferred onto
PVDF membranes (Thermo Fisher Scientific). Alexa680-conju-
gated secondary antibodies (Life Technologies) were used and
membranes were scanned using the Odyssey infrared imaging
system (Licor).
Confocal and electron microscopy
Cells were dropped on poly-lysine-coated slides (Thermo Fisher
Scientific) and fixed in PBS-paraformaldehyde 4%, either directly
or after previous mechanical dissociation. Immunofluorescence
was performed as previously described [11], using Alexa488-
conjugated secondary antibodies (Life Technologies). Samples
were mounted in DAPI-containing mounting medium (Prolong
gold antifade reagent, Life Technologies). Confocal acquisitions
were performed on TCS/SP4 Leica confocal microscope (Institut
A. Lwoff, Villejuif).
Following the indicated treatments, cells were collected and
fixed for electron microscopy (3% glutaraldehyde/PBS, 1 hour).
After incubation in 1% OsO4, cells were dehydrated in graded
dilutions of ethanol, embedded in artificial resin (Epon, Momen-
tive Specialty Chemicals) and processed for electron microscopy.
GSC morphology was monitored by transmission electron
microscopy (EM10CR, Zeiss, Imagery facility, Institut Cochin)
performed at 60–80 kV on unstained thin sections.
Flow cytometry
Apoptosis was evaluated using both the FITC Annexin V/Dead
Cell Apoptosis Kit as per the manufacturer’s instructions (Life
Technologies) and sub-G1/G0 population quantification. For the
latter, cells were fixed with cold ethanol 70% for 15 min, wash
twice with cold PBS, and RNase (100 mg/ml) and propidium
iodide (PI, 40 mg/ml, Calbiochem) were added to the samples 10
min prior analysis. Cell death was determined by PI staining
(50 mg/ml). Mean survival (PI exclusion) was calculated from 3
independent experiments. Statistical analyses were performed
using two-way Student’s test. All flow cytometry analyses were
performed on Accuri cytometer (BD Biosciences, CYBIO facility,
Institut Cochin) and processed using CFlow plus software (BD
Biosciences).
Results
Mitogen deprivation reduces GSC survival
Fourteen patient-derived GSCs, which efficiently form neuro-
spheres (NS) and express stem cell markers, such as the
transcription factor Sox2, among others, were maintained ex vivo
mTOR Addiction in Glioblastoma Stem-Like Cells
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in a serum-free medium containing a defined cocktail of mitogens
[10–13]. To study GSC behavior under deprivation conditions,
which could occur within the tumor mass, we first investigated self-
renewal ability in the absence of mitogens. Mitogen deprivation
dissipates self-renewal hallmarks, such as secondary NS formation
and nuclear expression of Sox2 (Fig. 1a-b), suggesting that
deprivation conditions lead to loss of GSC identity. We then
explored whether these culture conditions could promote GSC
differentiation, as changes in mitogen concentration have been
shown to contribute to differentiation of stem cells [16]. However,
the expression of the stemness markers, Sox2 and Nestin, was not
altered, at the RNA level, by mitogen withdrawal in non-adhesive
cultures, as compared to adherent and morphologically differen-
tiated GSCs (Fig. 1c-d). Meanwhile the expression of the astrocyte
intermediate filament protein, glial fibrillary acidic protein (GFAP)
was clearly turned on in adherent cells, while barely detectable in
either growing or mitogen-deprived GSCs (Fig. 1d). This suggests
that deprivation does not induce differentiation. Alternatively, the
failure in NS formation under mitogen-deprived conditions could
be due to either a reduction in GSC survival or the establishment
Figure 1. Mitogen deprivation reduced glioblastoma stem-like cell survival. a-h) GSCs were deprived from mitogens for 1 to 3 days. GSCs
growing in mitogen-supplemented medium were used as a control (C). a) The number of secondary neurospheres per field of view (NS/FOV) was
counted after 3 days of deprivation in GSCs #1-4. b) Sox2 levels (green) were analyzed by confocal in GSCs #1-4. Nuclei were counterstained with
DAPI (blue). Scale bar: 15 mm. c-d) Expression of Sox2 and Nestin as well as GADPH as a control, was evaluated by RT-PCR, while GFAP expression was
analyzed by confocal analysis. Differentiation of GSC#4 was induced as described in methods. e) PI incorporation was measured by flow cytometry
(10.000 events) in GSCs #1–14 and the percentage of cell death was estimated. Graph represents mean+s.d. of three independent experiments.
Student’s t-test: ***P,0.001, **P,0.01. f) Flow cytometry analysis (10.000 events) of Annexin V-FITC/Propidium Iodide (PI) staining was used to
measure cell death in GSC#1. Number of cells either viable (Annexin V/PI –/–) or in early (Annexin V/PI +/–), late apoptosis (Annexin V/PI +/+) and
necrotic (Annexin V/PI –/+) phases was expressed as percentage of total population. g) DNA profile was analyzed by flow cytometry with PI staining
in GSC#1. Percentage of apoptotic cells was calculated based on sub-G1 peak. Student’s t-test:
***P,0.001. h) Western blot analysis was conducted
using the indicated antibodies in GSC#1. Each panel is representative of three independent experiments.
doi:10.1371/journal.pone.0093505.g001
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of a quiescent non-proliferative state [17]. Of note, cell death was
increased in a panel of fourteen patient-derived GSCs cultured
under mitogen deprivation for three days (Fig. 1e). Flow cytometry
analysis of Annexin V/propidium iodide (PI) staining indicated
that mitogen deprivation indeed triggered apoptotic cell death, as
survival dropped from 75% to less than 30% after three days (Fig.
1f). Analysis of nuclear DNA content further showed that more
than 50% of three days-starved GSCs exhibited a sub-G1/G0
phase profile, typical of apoptosis-related DNA fragmentation (Fig.
1g). We next investigated the status of the mTor (mammalian
target of rapamycin) pathway, a crucial signaling nexus for GSC
integrity [18]. Notably, the phosphorylation of key mediators of
Figure 2. Mitogen deprivation triggers both autophagy and apoptosis. a-e) GSCs were deprived from mitogens for 1 to 3 days. GSCs
growing in mitogen-supplemented medium were use as a control (C). a) Electron microscopy analysis of mitogen-starved GSC#1. Left panels. Cells
presented morphological signs of apoptosis, including cytoplasmic blebbing, nuclear fragmentation and chromatin condensation. Scale bars: 2 mm.
Right panels. Different stages of autophagy can be seen, such as pre-autophagosome and early autophagosome (upper panels) and late
autophagosomes (autolysosomes/amphisomes, lower panels). Scale bars: 50 nm. b) Western blot analysis was conducted using the indicated
antibodies in GSC#1. ** non-processed form; * processed form. c-e) LC3B puncta, Atg12 aggregates and mitochondrial cytochrome c release were
analyzed by confocal microscopy. Scale bars: 5 mm (c,d) and 2.5 mm (e). f) GSC#1 were pre-treated with vehicle (DMSO) or QVD (10 mM) for 45 min
and mitogen-deprived for 3 days in the absence or presence of the drug. Flow cytometry analysis (10.000 events) of Annexin V-FITC/PI staining was
used to measure cell death in GSC#1. Number of cells either viable (Annexin V/PI –/–) or in early (Annexin V/PI +/–), late apoptosis (Annexin V/PI +/+)
and necrotic (Annexin V/PI –/+) phases was expressed as percentage of total population. g) GSC#1 were transfected with siRNA against Beclin-1 or a
control siRNA (siC) for 48 hours. Cells were mitogen-deprived as indicated and collected 5 days post-transfection. Beclin-1 protein levels were
analyzed by western-blot and cell death was examined as in f). h) GSC#1 were treated with vehicle (DMSO) or Chloroquine (CQ) (25 mM, XX min) in
mitogen-supplemented medium (C) and in mitogen-deprived conditions for 3 days (3d). Flow cytometry analysis (10.000 events) of Annexin V-FITC/PI
staining was used to measure cell death in GSC#1 as in f). Graph represents mean+s.d. of three independent experiments. Each panel is
representative of three independent experiments.
doi:10.1371/journal.pone.0093505.g002
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this molecular cascade, namely Akt, S6 and 4EBP, was
compromised as early as 24 hours post-starvation, suggesting that
mitogen additives sustain the constitutive activation of the mTor
pathway in GSCs (Fig. 1h). Together, this set of experiments
suggests that mitogen deprivation drives cell death in GSCs,
together with a decrease in mTor activation.
Mitogen deprivation triggers both autophagy and
apoptosis in GSCs
To better characterize how mitogen deprivation promoted cell
demise, GSC morphology was evaluated using electron microsco-
py (Fig. 2a). In deprived cells, both autophagic and apoptotic
signatures were clearly identified, such as double membrane
organelles and nuclear condensation, respectively. Moreover,
deprivation triggered the phosphorylation of key sensors of
autophagy [19,20], ie AMPK (AMP-activated protein kinase)
and its downstream target ACC (acetyl-coA carboxylase) (Fig. 2b).
Further confirming autophagosome formation, LC3B lipidation
and punctuation, and ATG12 aggregation, were increased (Fig.
2b-d) [21–23]. Paralleling autophagy induction, starvation also
induced dissipation of mitochondrial cytochrome c and cleavage of
the effector caspase-3, indicative of caspase-dependent apoptosis
(Fig. 2b, 2e). In agreement with these data, the expression of the
pro-survival Bcl2 protein was decreased over time, while that of
the pro-apoptotic BH3-only protein Bim gradually increased (Fig.
2b) [24]. Treatment with the broad-spectrum caspase inhibitor
QVD [25] minimized deprivation-induced GSC apoptosis and
partly restored cell survival (Fig. 2f). To next evaluate the
importance of autophagy in this process, the expression of
Beclin-1, a well-known regulator [26], was targeted by RNA
interference. Remarkably, deprivation-induced GSC apoptosis
was quelled when Beclin-1 levels were reduced (Fig. 2g).
Alternatively, treatment with the lysosomotropic agent Chloro-
quine, a widely use autophagy inhibitor, also reduced mitogen
deprivation-driven apoptosis (Fig. 2h). Taken together, our results
show that GSC viability relies on the availability of mitogens, as
withdrawal results in autophagy and apoptosis.
mTor inhibition provokes autophagy and apoptosis in
GSCs
Although the mTor pathway has been linked to autophagy and
cell death in the bulk of cancer cells [27], its involvement in cancer
stem cell survival is unclear. In that view, mTor was pharmaco-
logically inhibited in GSCs through four different means:
LY294002, rapamycin, PP242, and PI103, which target PI3K,
mTor complex 1, mTOR kinase activity, and both PI3K and
mTor, respectively [11,28]. A 24 hour-treatment of GSCs cultured
in mitogen-containing medium strongly impaired mTor signaling,
and led to LC3B lipidation and punctated staining (Fig. 3a-b). As a
consequence, cell viability was gradually reduced (Fig. 3c). Thus,
mTor activity is required to restrain GSC apoptosis and
autophagy. Strikingly, inhibition of caspase-dependent apoptosis
with QVD restored both the activation of the mTor pathway and
low levels of LC3B lipidation under deprivation conditions (Fig.
3d-e). On the other hand, knocking down Beclin-1 modestly, but
consistently, contravened mitogen withdrawal-induced mTor
inhibition (Fig. 3f-g). Therefore, blockade of either autophagy or
apoptosis can restore mTor pathway activation in patient-derived
GSCs.
Figure 3. mTOR inhibition provokes autophagy and apoptosis in GSC. a-c) GSC#1 were treated with DMSO (–), LY294002 (LY, 10 mM),
Rapamycin (RP, 50nM), PP242 (PP, 1 mM) and PI103 (PI, 10 mM). a) Protein lysates were analyzed after 1 day by western blot for the indicated
antibodies. b) LC3B puncta were examined under confocal microscope after 3 days. Scale bars: 5 mm. c) Flow cytometry analysis of Annexin V-FITC/PI
staining was performed as described in 2f). d-g) GSC#1 were pre-treated with vehicle (DMSO) or QVD (10 mM) for 45 min and mitogen-deprived for 3
days in the absence or presence of the drug (d-e). Alternatively, GSC#1 were transfected with siRNA against Beclin-1 or a control siRNA (siC) for 48
hours. Cells were mitogen-deprived as indicated and collected 5 days post-transfection (f-g). Protein extracts were analyzed by western blot for the
indicated antibodies (d, f). ** non-processed form; * processed form. LC3B staining was examined by confocal microscopy (e, g). Scale bars: 5 mm.
Graph represents mean+s.d. of three independent experiments. Each panel is representative of three independent experiments.
doi:10.1371/journal.pone.0093505.g003
mTOR Addiction in Glioblastoma Stem-Like Cells
PLOS ONE | www.plosone.org 5 March 2014 | Volume 9 | Issue 3 | e93505
Brain endothelial cells protect GSCs from mitogen
deprivation-induced cell death
GSCs reside within a vascular niche, which provides a specific
and confined microenvironment that is involved in the regulation
of stem cell self-renewal and fate [11,29–31]. Because the brain
endothelial cell secretome modulates the mTor signaling nexus in
GSCs [11,18], we hypothesized that it might function as a
gatekeeper against mitogen deprivation-induced cell death. To test
this hypothesis, GSCs were cultured with endothelial cell
conditioned medium (EC-CM) in the absence of other additives.
In this condition, fewer autophagic and apoptotic features were
observed by electron microscopy, when compared to deprived
cells (Fig. 4a). Endothelium-derived factors also protected GSCs
from deprivation-induced autophagy and apoptosis, as illustrated
by the absence of lipidated and punctated LC3B, reduced Bim
levels, enhanced cell viability and decreased cell death (Fig. 4b-f).
Thus, endothelial-derived factors preserve mTor activation and
thereby allow GSC self-renewal, in the absence of mitogen
additives.
Discussion
Cancer stem cells (CSCs) initiate tumor formation, contribute to
relapse and, consequently constitute a promising cellular target to
contain tumor progression. Different options can be considered
to limit CSC maintenance and self-renewal, such as promoting
their differentiation, reducing their interaction with blood vessels
Figure 4. Brain endothelial cells protect GSC against mitogen deprivation-induced autophagy and apoptosis. a-d) GSC#1 were
cultured for 3 days with control medium (C), deprivation medium (3d) or endothelial-derived conditioned medium (EC-CM). a) Electron microscopy
analysis revealed a protective effect of EC-CM against apoptosis when compared to 3 day-starved cells. Scale bars: 1 mm. b) Protein extracts were
analyzed by western blot for the indicated antibodies. ** non-processed form; * processed form. c) GSCs #1–14 were cultured for 3 days with
deprivation medium or EC-CM and PI incorporation was measured by flow cytometry. Percent of cell death was represented as the mean+s.d. of three
independent experiments. Student’s t-test: ***P,0.001, **P,0.01, *P,0.05. d) LC3B puncta was examined by confocal microscopy. Scale bars: 5 mm. e-
f) Annexin V-FITC/PI staining (e), as well as PI staining alone (f), were used to evaluate apoptosis as described in 1f-g. Each panel is representative of
three independent experiments. g) Schematic representation of the central role of mTor in regulating mitogen deprivation-induced autophagy and
apoptosis in GSCs (left panel). The positive effect of endothelial factors on this pathway is illustrated (right panel).
doi:10.1371/journal.pone.0093505.g004
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and inducing cell death [32,33]. For instance, it has been
described that anti-angiogenic therapies elicit GSC disappearance
[9]. However, the molecular mechanisms involved are not fully
elucidated yet. Therefore, understanding how CSCs survive and
interact with their microenvironment is of great importance for the
future development of specific strategies to eradicate this cell
population. In the present work, we studied the behavior of GBM
patient-derived stem-like cells under deprivation conditions,
reminiscent of that found in glioblastoma. Using this ex vivo tool,
we report that mitogens and endothelial-secreted factors sustain
mTor activation, which in turn precludes both apoptosis and
autophagy. Interestingly, apoptosis and autophagy can operate a
negative feedback loop on mTor, since inhibition of either of these
processes can restore mTor activation under deprivation condi-
tions. Although the molecules involved in this loop are not
identified yet, it is tempting to postulate that downstream targets of
mTor could operate a positive control on the pathway. Collec-
tively, our data support the notion that mTor centrally controls the
fate of GSCs.
Electron microscopy analysis of mitogen-deprived GSCs
revealed the progressive appearance of morphological features of
both autophagy and apoptosis, which were further confirmed at
the biochemical level. Likewise, our work illustrates how
autophagy and apoptosis are orchestrated upon growth factor
removal (Fig. 4g). Since Beclin-1 depletion, as well as chloroquine
treatment impair both deprivation-induced autophagy and apop-
tosis, autophagy might be a necessary step for deprivation-induced
cell death in GSCs. However, apoptosis inhibition can bypass
deprivation-induced autophagy, indicating that these processes are
inextricably interrelated. A potential molecular link could be the
mTor pathway. Indeed, while aberrantly hyper-activated in GSCs,
the efficient obstruction of the mTor pathway through well-known
inhibitors not only provokes autophagy, but also induces apoptosis
in a similar trend to that of mitogen deprivation. Thus, inhibition
of this signaling axis might occur upstream of both processes.
More interestingly, blockade of either apoptosis or autophagy
seems to be sufficient to guarantee mTor activation even in
deprivation conditions. Our results thus suggest that mTor plays
an instrumental role in GSC survival, reinforcing the idea that
GSCs are addicted to mTor for their survival. Indeed, beyond the
canonical actions of the mTor signaling nexus in mitogen
deprivation-induced cell death and autophagy, we now report
an unexpected retroactive feedback loop, where blocking these two
events can re-initiate mTor activity. This strongly suggests that
GSCs rely on the mTor pathway for their survival and that its
sustained activity is sine qua non to maintain the GSC population.
Thus, mTor signaling can control GSC viability through a two-
pronged mechanism involving apoptosis and autophagy (Fig. 4g).
To conclude, our results support the concept that endothelial cells
could antagonize the negative reciprocal loop that suppress the
mTor pathway in a hostile microenvironment, as mimicked by the
absence of mitogens.
It is widely recognized that stem cell niches include a vascular
structure, and are responsible for controlling local metabolic
conditions, secreted protein concentrations, cell adhesion and
communication to the surrounding matrix and neighboring cells
[11,29–31]. Importantly, GSCs have been identified in close
proximity to brain endothelial cells, while targeting the tumor
vasculature depletes the self-renewing GSC sub-population and
impairs brain tumor growth [9]. In vitro, endothelial cells secrete
protein factors that can sustain mTor activation [11]. In this
report, we demonstrate that endothelial secreted factors act as
trophogens that sustain GSC viability. This relies most likely on
the ability of the endothelial secretome to secure neurosphere
integrity and mTor activity. Therefore, this study strengthens the
emerging concept that the brain vasculature supplies essential
signals to maintain the cancer stem-like cell population in
glioblastoma.
In summary, mitogen deprivation-induced cell death depends
on mTor inactivation in GSCs. Likewise, pharmacological
inhibition of mTor promotes cell death (Fig. 4g, left panel).
Conversely, either endothelial factors or blockade of autophagy
and apoptosis restores mTor signaling (Fig. 4g, right panel). Our
results highlight the role of mTor as a keystone for GSC
maintenance and support the concept of GSC addiction to this
pathway for their survival. Although further studies are required to
fully uncover the molecular mechanisms implicated in the
regulation of mTor status in the tumor microenvironment,
altering its activity might be an effective therapeutic strategy for
future GBM treatment.
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